Catalyst Pharmaceuticals, Inc.
CPRX
$23.10
$0.482.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 52.36% | 206.19% | 203.07% | 129.50% | 130.18% |
| Total Depreciation and Amortization | 0.89% | 3.43% | 5.86% | 14.88% | 53.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 101.72% | -95.70% | -99.69% | -90.56% | -86.56% |
| Change in Net Operating Assets | -220.98% | 513.81% | 260.10% | 182.83% | 199.59% |
| Cash from Operations | 4.49% | 39.76% | 63.91% | 67.00% | 75.41% |
| Capital Expenditure | 99.69% | 98.97% | 99.02% | 99.72% | 77.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 97.60% |
| Cash from Investing | 99.71% | 99.72% | 99.73% | 99.81% | 84.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -87.42% | -88.34% | -88.35% | 5,434.20% | 2,715.55% |
| Repurchase of Common Stock | -101.67% | -101.67% | -55.99% | 31.98% | 11.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 65.90% | 1.08% | 2.21% | -4.07% | -4.00% |
| Cash from Financing | -90.40% | -98.18% | -97.94% | 1,395.62% | 1,807.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.96% | 40.73% | 66.65% | 336.33% | 337.88% |